Depressive Disorder: all 4,847 studies

Page 6 of 49. Open to participants first (509), then studies with results posted, then the rest; newest registration first within each.

• Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis UseRecruitingNCT03601026Not applicable
• Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar DepressionRecruitingNCT03522545Phase 1
• A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar DepressionRecruitingNCT03423680Phase 3
• rTMS Response Trajectories in DepressionRecruitingNCT03348761Not applicable
• Brain Connectivity in DepressionRecruitingNCT03276793Not applicable
• Feedback to Improve Depression OutcomesRecruitingNCT03162211Not applicable
• Schema Therapy for Chronic DepressionRecruitingNCT03084744Not applicable
• Personalized Indications for CBT and Antidepressants in Treating DepressionRecruitingNCT02752542Phase 4
• The Canadian Depression Research and Intervention Network (CDRIN) Maritimes RegistryRecruitingNCT02443636
• Pilot Study of Personalized Aperiodic Transcranial Alternating Current Stimulation in Antenatal Depression (PandA-tACS)TerminatedNCT06979154Not applicableResults posted
• Cognitive Behavioral Immersion: A Randomized Control Trial of Peer-Based Coaching in the MetaverseCompletedNCT06418997Not applicableResults posted
• A Trial to Assess a Wearable Patch's Functioning to Detect Medication IngestionCompletedNCT06372210Not applicableResults posted
• A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive DisorderCompletedNCT06340958Phase 2Results posted
• MBCT Intervention: Healthy Mind, Healthy LivingCompletedNCT05965349Not applicableResults posted
• A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With DepressionCompletedNCT05932407Results posted
• C-STRESS: A Mental Health App for College Students With DepressionTerminatedNCT05776901Early Phase 1Results posted
• Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of DepressionCompletedNCT05772702Not applicableResults posted
• The Effect of Logotherapy-Based Intervention on Depression Patients on Depression,Psychological Pain and Meaning of LifeCompletedNCT05702736Not applicableResults posted
• Equity Using Interventions for Pain and Depression - Pilot StudyCompletedNCT05695209Not applicableResults posted
• Augmenting Single-session Behavioral Activation (BA) With Delta-beta Transcranial Alternating Current Stimulation (tACS) for the Treatment of DepressionCompletedNCT05693922Not applicableResults posted
• Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)CompletedNCT05686408Phase 2Results posted
• [Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]TerminatedNCT05551195Not applicableResults posted
• Dynamic Neural Mechanisms of Brexanolone-induced Antidepressant Effects in Postpartum DepressionCompletedNCT05543746Results posted
• Bridging the Gap From Postpartum to Primary CareCompletedNCT05543265Not applicableResults posted
• Study to Evaluate Treatment Effects Associated With the NeuroStar SoftStart Treatment FeatureCompletedNCT05535062Not applicableResults posted
• Self-guided Treatment for Adolescents Navigating DepressionCompletedNCT05462652Not applicableResults posted
• Fluoxetine Treatment of Depression in Down SyndromeCompletedNCT05458479Phase 4Results posted
• Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD)CompletedNCT05454410Phase 2Results posted
• Self-compassion Therapist-led Online Group Treatment for Adolescents With Distress, Anxiety, and DepressionCompletedNCT05448014Not applicableResults posted
• ANC-501 in the Treatment of Adults With Major Depressive DisorderCompletedNCT05439603Phase 2Results posted
• Group Depression Treatment for Autistic YouthCompletedNCT05430022Not applicableResults posted
• Video-visit Behavior Therapy for Anxiety and Depression in YouthCompletedNCT05417412Not applicableResults posted
• Technology Enabled Services to Enhance Depression CareCompletedNCT05406791Not applicableResults posted
• Therapist-Guided Smartphone-Delivered CBT for MDDCompletedNCT05386329Not applicableResults posted
• Cranial Electrotherapy Stimulation for the Treatment of Major Depressive Disorder in AdultsCompletedNCT05384041Not applicableResults posted
• iTBS in Bipolar I DepressionCompletedNCT05375214Not applicableResults posted
• Feasibility of a Culturally Adapted Emotional-Behavioral Prevention Program for American Indian ChildrenCompletedNCT05371665Not applicableResults posted
• Effectiveness and Tolerability of аgomelatine in the Treatment of Patients With Depression After SARS-CoV-2 (TELESPHOR)CompletedNCT05323994Results posted
• Community Health Worker Training to Reduce Depression and Substance Use Stigma in TB/HIV Care in South AfricaCompletedNCT05282173Not applicableResults posted
• Intensive TMS for Bipolar DepressionCompletedNCT05228457Not applicableResults posted
• Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on HealthCompletedNCT05206734Results posted
• KAP for Depression in Abstinent Opioid UsersTerminatedNCT05193318Phase 2Results posted
• A Pilot Study of the Immediate Effects of DLPFC tDCS on Attention Bias in DepressionCompletedNCT05188248Not applicableResults posted
• A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.TerminatedNCT05169710Phase 3Results posted
• Ketamine + Mindfulness for DepressionCompletedNCT05168735Phase 1/2Results posted
• Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDDCompletedNCT05165394Phase 2Results posted
• CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language TechnologiesCompletedNCT05127837Not applicableResults posted
• A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRDCompletedNCT05113771Phase 2Results posted
• Substudy of Protocol NCT03843957 - Effect of mPATH on Screening for Depression, Fall Risk, and SafetyCompletedNCT05110014Not applicableResults posted
• Investigating the Causal Role of Prefrontal Control in Decision-making in Patients With AnhedoniaCompletedNCT05084924Not applicableResults posted
• A Study to Assess the Efficacy and Safety of REL-1017 as Monotherapy for Major Depressive Disorder (MDD)CompletedNCT05081167Phase 3Results posted
• Digital Intervention to Treat Anxiety and Depression Among Persons Receiving Treatment for Opioid Use DisorderCompletedNCT05047627Not applicableResults posted
• Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic TargetsCompletedNCT05046184Phase 2Results posted
• Effects of Open-label Placebos on COVID-related Psychological HealthCompletedNCT05035550Not applicableResults posted
• Vortioxetine to Prevent Return of Symptoms in Children With DepressionTerminatedNCT05014919Phase 3Results posted
• Vagal Nerve Stimulation for Treatment Resistant Major DepressionCompletedNCT04990687Not applicableResults posted
• Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderCompletedNCT04985942Phase 3Results posted
• Targeting IL-17A for Treatment-Resistant DepressionCompletedNCT04979910Phase 2Results posted
• Mental Health Associations With VitiligoCompletedNCT04953338Results posted
• Virtual Reality Biofeedback for Postpartum Anxiety and DepressionCompletedNCT04925765Not applicableResults posted
• Repeated Neurocognitive Measurements in Depressed PatientsCompletedNCT04916548Phase 1/2Results posted
• Use of a Digitally Enabled App With Clinical Team Interface in the Management of DepressionCompletedNCT04891224Not applicableResults posted
• Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic DepressionCompletedNCT04876521Phase 4Results posted
• Safety of REL-1017 for Major Depressive DisorderCompletedNCT04855760Phase 3Results posted
• Stress and the Sympathetic Nervous System in Adults With DepressionCompletedNCT04838262Not applicableResults posted
• Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive DisorderCompletedNCT04830215Phase 4Results posted
• Antidepressant Effects of TS-161 in Treatment-Resistant DepressionTerminatedNCT04821271Phase 2Results posted
• Home-based tDCS in Major Depressive DisorderCompletedNCT04799405Not applicableResults posted
• Integrating a Stepped Care Model of Screening and Treatment for Depression Into Malawi's National HIV Care Delivery PlatformCompletedNCT04777006Phase 4Results posted
• Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive DisorderCompletedNCT04770285Not applicableResults posted
• A Pilot Randomized Trial of Video-based Family Therapy for Depressed Home Visited MothersCompletedNCT04741776Not applicableResults posted
• The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant DepressionCompletedNCT04739865Phase 2Results posted
• Phase 1 Evaluation of (2R,6R)-HydroxynorketamineCompletedNCT04711005Phase 1Results posted
• Antidepressant Response in Older Adults With Comorbid PTSD and MDDTerminatedNCT04697693Phase 4Results posted
• A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)CompletedNCT04688164Phase 3Results posted
• Positive Processes and Transition to HealthCompletedNCT04678232Not applicableResults posted
• BRITEPath- Phase 2CompletedNCT04672798Not applicableResults posted
• Levodopa and Exercise for Older Adults With Depression and Psychomotor SlowingTerminatedNCT04650217Phase 4Results posted
• Screening Wizard- Phase 2CompletedNCT04646369Not applicableResults posted
• Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19CompletedNCT04634903Not applicableResults posted
• Electroconvulsive Therapy Amplitude TitrationCompletedNCT04621786Not applicableResults posted
• A Trial of "Opening Doors to Recovery" for Persons With Serious Mental IllnessesCompletedNCT04612777Not applicableResults posted
• A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant DepressionCompletedNCT04599855Phase 4Results posted
• A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant TherapyTerminatedNCT04532749Phase 3Results posted
• In-person vs. Remote Wellness SupportCompletedNCT04526067Not applicableResults posted
• A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19CompletedNCT04524598Not applicableResults posted
• A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With DepressionCompletedNCT04521478Phase 2Results posted
• Message-Based Psychotherapy and Digital Treatment Sequences for DepressionCompletedNCT04513080Not applicableResults posted
• A Pilot Study of Creatine Monohydrate as an Augmenting Agent for ECT in Persons With Major Depressive DisorderCompletedNCT04504253Phase 3Results posted
• Ketamine for Older Adults PilotCompletedNCT04504175Phase 4Results posted
• A Smartphone-Assisted Brief Behavioral Intervention for Pregnant Women With DepressionCompletedNCT04495166Not applicableResults posted
• 1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)TerminatedNCT04493320Phase 4Results posted
• Social Reward and Its Effect on Brain Functions in Psychotherapies for Mid- and Late-Life DepressionCompletedNCT04487730Not applicableResults posted
• iTBS for Adolescent Depression: An Open Label Study Evaluating Safety and Efficacy of TreatmentCompletedNCT04485455Not applicableResults posted
• A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive DisorderCompletedNCT04479852Phase 2Results posted
• A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive DisorderCompletedNCT04476030Phase 3Results posted
• Vagus Nerve Stimulation: Integration of Behavior and Cardiac ModulationCompletedNCT04467164Not applicableResults posted
• A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)CompletedNCT04442503Phase 3Results posted
• A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)CompletedNCT04442490Phase 3Results posted
• eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes RiskCompletedNCT04437485Phase 2Results posted

← Depressive Disorder overview